We subsequently segregated PAD patients according to mild disease (Fontaine Stages I and II), or severe disease (Fontaine Stages III and IV); we did not observe any significant differences either in plasma galectin-3 concentrations, or in any of the other biochemical variables studied; the concentrations were increased with respect to the control group (Figure 4). Here, LGALS3 is linked to peripheral arterial disease.